Scarica l'app Stockscreener
2.37
2.47%
-0.06
Precedente Chiudi:
$2.43
Aprire:
$2.46
Volume 24 ore:
216.56K
Relative Volume:
0.14
Capitalizzazione di mercato:
$62.81M
Reddito:
-
Utile/perdita netta:
$-30.26M
Rapporto P/E:
-1.1618
EPS:
-2.04
Flusso di cassa netto:
$-24.69M
1 W Prestazione:
-4.82%
1M Prestazione:
-24.04%
6M Prestazione:
-12.22%
1 anno Prestazione:
-8.85%
Intervallo 1D:
$2.365
$2.55
Intervallo di 1 settimana:
$2.29
$2.65
Portata 52W:
$1.11
$5.50
Annovis Bio Inc Stock (ANVS) Company Profile
Nome
Annovis Bio Inc
Settore
Industria
Telefono
484-875-3192
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Compare ANVS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.37 | 64.40M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-10-25 | Aggiornamento | Maxim Group | Hold → Buy |
| 2023-12-29 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
Annovis Bio Inc Borsa (ANVS) Ultime notizie
Will Annovis Bio Inc. stock recover after earningsTrade Analysis Summary & Long-Term Growth Portfolio Plans - mfd.ru
Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod - TipRanks
Annovis Bio, Inc. Secures DSMB Approval for Phase 3 Trial - TradingView
Annovis Bio Receives Positive Safety Recommendation from DSMB for Buntanetap in Alzheimer's Phase 3 Trial - Quiver Quantitative
Annovis Bio, Inc. (ANVS) recently announced that its independent Data Safety Monitoring Board (DSMB) has officially approved the company to proceed with the pivotal Phase III clinical trial of Buntanetap for the treatment of Alzheimer's disease. - Bitget
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease - ChartMill
Annovis Bio (NYSE:ANVS) Shares Down 1%Here's Why - MarketBeat
Is Annovis Bio Inc. part of any major indexEntry Point & Long Hold Capital Preservation Tips - mfd.ru
CEO Moves: Should you avoid Annovis Bio Inc. stock right nowJuly 2025 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Can Annovis Bio Inc. deliver consistent dividendsJuly 2025 Technicals & Reliable Entry Point Alerts - mfd.ru
How Annovis Bio Inc. stock performs during Fed tightening cyclesJuly 2025 News Drivers & Real-Time Stock Price Movement Reports - mfd.ru
Highs Report: Should you avoid Annovis Bio Inc stock right nowQuarterly Investment Review & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Stock Market Recap: Will Annovis Bio Inc. benefit from rising consumer demand2025 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn
Portfolio Recap: Will APA Corporation outperform its industry peersWeekly Risk Summary & High Yield Stock Recommendations - baoquankhu1.vn
Annovis Bio Hosts Regulation FD Investor Information Webinar - TipRanks
Annovis Bio, Inc. Announces Progress in Alzheimer's and Parkinson's Trials - TradingView
Hedge Fund Bets: Will Annovis Bio Inc stock hit new highs in YEARJuly 2025 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Aug Rallies: Is Annovis Bio Inc a defensive stockQuarterly Profit Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-01-26 04:28:37 - baoquankhu1.vn
US Market Wrap: Can Annovis Bio Inc deliver consistent dividendsJuly 2025 Momentum & Capital Efficient Trading Techniques - baoquankhu1.vn
Movement Recap: What are the future prospects of XPeng Inc Depositary ReceiptWeekly Stock Analysis & Consistent Return Investment Signals - baoquankhu1.vn
Annovis Bio, Inc. (NYSE:ANVS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Annovis Bio Appoints Hui Liu as Director of Biostatistics - MSN
Parkinson’s Breakthrough? New Data Shows Drug May Reverse Cognitive Decline - MSN
Value Recap: What are Hess Corporations earnings expectationsMarket Trend Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Aug Outlook: Is TOMI Environmental Solutions Inc in accumulation or distribution phase2025 Technical Patterns & Weekly High Conviction Ideas - baoquankhu1.vn
Stop Loss: Is Annovis Bio Inc stock a smart retirement pickJuly 2025 Market Mood & Smart Swing Trading Alerts - baoquankhu1.vn
Can Annovis Bio Inc. stock surprise with earnings upside2025 Buyback Activity & Verified Chart Pattern Signals - Улправда
What is the fair value of Annovis Bio Inc. stock nowJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - Улправда
How Annovis Bio Inc. stock reacts to oil prices2025 Biggest Moves & Daily Profit Maximizing Tips - Улправда
Will Annovis Bio Inc. stock maintain momentum in 2025Earnings Trend Report & Safe Swing Trade Setups - Улправда
Why Annovis Bio Inc. stock remains on watchlistsWeekly Gains Report & Safe Entry Zone Identification - Улправда
Will Annovis Bio Inc. stock outperform Nasdaq index2025 Trading Volume Trends & Intraday High Probability Setup Alerts - ulpravda.ru
2026 world cup match preview guide: Will Annovis Bio Inc. stock attract ESG investors2026 world cup usa national team qualification defensive leaders counter attacking group prediction tactical review - Улправда
Published on: 2026-01-06 13:56:48 - ulpravda.ru
Annovis Bio stock hits 52-week low at $4.05 amid market challenges - MSN
New trial offers extended buntanetap access for people with Parkinson’s - Parkinson's News Today
Breakout Watch: How Annovis Bio Inc stock reacts to oil pricesOptions Play & Reliable Intraday Trade Alerts - moha.gov.vn
Annovis Bio stock rating cut to hold at D. Boral Capital - MSN
History Review: Is Annovis Bio Inc stock attractive for growth ETFsJuly 2025 Update & Breakout Confirmation Alerts - moha.gov.vn
Annovis sets investor webinar as neurodegeneration pipeline reaches inflection - MSN
Annovis Bio, Inc. (NYSE:ANVS) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Published on: 2025-12-25 20:53:49 - moha.gov.vn
Annovis Launches 3-Year Parkinson’s Study to Test Long-Term Promise of Drug - MyChesCo
Annovis Sets Investor Webinar as Neurodegeneration Pipeline Reaches Inflection - MyChesCo
Inflation Data: Is Annovis Bio Inc. stock positioned for secular growthTrade Risk Summary & Verified Stock Trade Ideas - Улправда
Why analysts remain bullish on Annovis Bio Inc. stockJuly 2025 Technicals & Short-Term Swing Trade Alerts - Улправда
Is Annovis Bio Inc. stock positioned for secular growthMarket Activity Recap & AI Driven Price Predictions - Улправда
Volume Summary: Can Annovis Bio Inc. stock hold up in economic slowdownShort Setup & Technical Pattern Alert System - moha.gov.vn
What technical patterns form on Annovis Bio Inc. stock chartsTrade Entry Report & Technical Confirmation Alerts - Улправда
Why Annovis Bio Inc. stock appears on watchlistsJuly 2025 Summary & Stepwise Trade Signal Guides - DonanımHaber
Annovis Bio Inc Azioni (ANVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):